DS

Donna M. Shattuck-Eidens

MG Myriad Genetics: 5 patents #21 of 138Top 20%
UU University Of Utah: 4 patents #204 of 1,848Top 15%
TI The Cancer Institute: 2 patents #15 of 25Top 60%
US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
📍 Salt Lake City, UT: #590 of 4,590 inventorsTop 15%
🗺 Utah: #2,564 of 19,430 inventorsTop 15%
Overall (All Time): #666,807 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
6162897 17q-linked breast and ovarian cancer susceptibility gene Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb +4 more 2000-12-19
5753441 170-linked breast and ovarian cancer susceptibility gene Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb +4 more 1998-05-19
5747282 17Q-linked breast and ovarian cancer susceptibility gene Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb +4 more 1998-05-05
5710001 17q-linked breast and ovarian cancer susceptibility gene Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb +4 more 1998-01-20
5709999 Linked breast and ovarian cancer susceptibility gene Jacques Simard, Francine Durocher, Mitsuuru Emi, Yusuke Nakamura 1998-01-20
5693473 Linked breast and ovarian cancer susceptibility gene Jacques Simard, Francine Durocher, Mitsuuru Emi, Yusuke Nakamura 1997-12-02
5443978 Chrysanthemyl diphosphate synthase, corresponding genes and use in pyrethrin synthesis Suzanne R. Ellenberger, Galen D. Peiser, Russell N. Bell, Charles E. Hussey, Jr., Bradley D. Swedlund 1995-08-22
5324631 Method and device for improved restriction fragment length polymorphism analysis Timothy G. Helentjaris 1994-06-28